Lucas B. Sullivan
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 18
- Molecular Biology top 1%
- Mitochondrial Function and Pathology 7
- Metabolism, Diabetes, and Cancer 7
- Metabolomics and Mass Spectrometry Studies 5
- Epigenetics and DNA Methylation 4
- Biochemistry top 1%
- Amino Acid Enzymes and Metabolism 3
- Clinical Biochemistry top 2%
- Aging top 5%
-
- Pancreatic function and diabetes 6
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Navdeep S. ChandelMatthew G. Vander HeidenDan Y. GuiAaron M. HosiosWilliam W. WheatonElizaveta FreinkmanRalph J. DeBerardinisAndrew R. Mullen
- Partner nations
- United StatesSouth AfricaFinland
In The Last Decade
Lucas B. Sullivan
33 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 3.2k
- Molecular Biology 4.4k
- Biochemistry 435
- Clinical Biochemistry 250
- Aging 50
Countries citing papers authored by Lucas B. Sullivan
This map shows the geographic impact of Lucas B. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas B. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas B. Sullivan more than expected).
Fields of papers citing papers by Lucas B. Sullivan
This network shows the impact of papers produced by Lucas B. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas B. Sullivan. The network helps show where Lucas B. Sullivan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lucas B. Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 46 | |
| 6 | A non-canonical tricarboxylic acid cycle underlies cellular identitybreakdown → | 2022 | 172 |
| 7 | 2022 | 34 | |
| 8 | 2020 | 51 | |
| 9 | 2020 | 32 | |
| 10 | Increased demand for NAD+ relative to ATP drives aerobic glycolysisbreakdown → | 2020 | 351 |
| 11 | 2018 | 243 | |
| 12 | 2017 | 37 | |
| 13 | 2016 | 107 | |
| 14 | Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancerbreakdown → | 2016 | 554 |
| 15 | Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cellsbreakdown → | 2015 | 779 |
| 16 | Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesisbreakdown → | 2014 | 858 |
| 17 | 2013 | 6 | |
| 18 | 2013 | 239 | |
| 19 | Reductive carboxylation supports growth in tumour cells with defective mitochondriabreakdown → | 2011 | 1004 |
| 20 | Sickle cell: the significance of screening. | 1977 | 2 |
About Lucas B. Sullivan
Lucas B. Sullivan is a scholar working on Cancer Research, Aging and Biochemistry, having authored 36 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (18 papers), Mitochondrial Function and Pathology (7 papers), Metabolism, Diabetes, and Cancer (7 papers), Pancreatic function and diabetes (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Epigenetics and DNA Methylation (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Cancer Research (3.2k citations), Molecular Biology (4.4k citations) and Biochemistry (435 citations). Lucas B. Sullivan has collaborated with scholars based in United States, South Africa and Finland. Frequent co-authors include Navdeep S. Chandel, Matthew G. Vander Heiden, Dan Y. Gui, Aaron M. Hosios, William W. Wheaton, Elizaveta Freinkman, Ralph J. DeBerardinis, Andrew R. Mullen, Éric Dufour and Tzuling Cheng. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.